Abnormal Thickening Identified as Endometrial Hyperplasia

Description

Centered in the pelvis, the uterus is rendered with the fundus superior and the cervix inferior, with the uterine cavity opened to emphasize an abnormally thickened endometrial mucosa. The hypertrophic endometrium lines the cavity and sits immediately internal to the myometrium, narrowing the endometrial lumen and accentuating the endometrial stripe relative to the muscular uterine wall. Laterally, the fallopian tubes extend from the uterine cornua toward the ovaries, which lie posterolateral to the uterus at the tubal fimbrial ends; the cervix continues inferiorly into the endocervical canal. Endometrial hyperplasia is the teaching diagnosis for a thickened uterine lining in the setting of abnormal uterine bleeding, most often from unopposed estrogen exposure (anovulatory cycles, polycystic ovary syndrome, obesity, exogenous estrogen, or tamoxifen). It matters because complex hyperplasia with atypia increases the likelihood of progression to endometrioid adenocarcinoma, and management hinges on distinguishing benign proliferative change from premalignant disease on endometrial sampling. A thick endometrium on transvaginal ultrasound often triggers hysteroscopy with biopsy or dilation and curettage, and this view supports that workup by keeping the cavity, endometrial surface, and cervix in clear relationship. Bleeding drives the consult. Use this illustration in gynecology and pathology curricula to explain endometrial cycling versus hyperplasia, and in clinical handouts or journal figures addressing evaluation of postmenopausal bleeding, sonographic endometrial thickness thresholds, and biopsy indications. It also fits oncology education discussing the hyperplasia to carcinoma sequence and the role of progestin therapy versus hysterectomy in atypical cases. Anatomical accuracy verified by SciePro's Medical Advisory Board.